Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13).
      Google Scholar   
Citation:
Ann Oncol vol 37 (2) 271-277
Year:
2026
Type:
Manuscript
Funding:
AFT
Endpoint:
Primary
Analysis:
Long-Term-Followup
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
15
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
ABCSG, ECOG-ACRIN, NSABP Foundation, GBG, BIG  
Corr. Author:
 
Authors:
                                                                                 
Networks:
AL068, BHCRN, CAPITAL, LAPS-CT018, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NY016, NEWMEXICO, VT004   
Study
AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: